FrontPage is India's Stock Market Social Network
Join 3,00,000+ Traders and Investors
AJANTPHARM Consensus Forecast
No. of reports in last year
3
No. of analysts
3
Average Consensus Forecast
2466.67
Consensus Potential
48.23%
AJANTPHARM Price Target Potential
| Brokerage | Target | Potential |
|---|---|---|
| Motilal Oswal | 2500 | 48.94% |
| Ajcon Global | 2400 | 46.81% |
| ICICIdirect.com | 2500 | 48.94% |
AJANTPHARM Ratings
Long term AJANTPHARM rating by FrontPage users
- ★★
- ★★
- ★★
- ★★
- ★★
5/5 (1 Ratings)
3 AJANTPHARM share price target reports by brokerages below. See what is analyst's view on AJANTPHARM share price forecast, rating, estimates, valuation and prediction behind the target. You may use these research report forecasts for long-term to medium term for your investment or trades in 2020.
- Home
- AJANTPHARM Forum
- AJANTPHARM Price Target
AJANTPHARM Share Price Target
AJANTPHARM Share Price Target - Broker Reports - 2022
Motilal Oswal
Price @ Call: 1934
22-Mar-22
Target: 2500
BUY
Ajcon Global
Price @ Call: 1720.7
8-Mar-22
Target: 2400
BUY
AJANTPHARM Share Price Target - Broker Reports - 2021
ICICIdirect.com
Price @ Call: 2126
31-Oct-21
Target: 2500
BUY
ICICIdirect.com
Price @ Call: 2289.1
30-Jul-21
Target: 2695
BUY
Motilal Oswal
Price @ Call: 2289.1
30-Jul-21
Target: 2780
BUY
Motilal Oswal
Price @ Call: 1743.47
2-Feb-21
Target: 2030
BUY
AJANTPHARM Share Price Target - Broker Reports - 2020
Motilal Oswal
Price @ Call: 1416.72
27-Feb-20
Target: 1655
BUY
We remain positive on AJP given the improving prospects of a revival in its earnings growth. Furthermore, capex is nearly complete and benefits are likely to accrue from end-FY20. We value AJP at 22x 12M forward earnings (superior profitability and return ratios) and arrive at a price target of INR1,655. Re-iterate Buy.
Motilal Oswal
Price @ Call: 1198.1
6-Feb-20
Target: 1435
BUY
We expect 16% earnings CAGR over FY19-22E, led by 14% DF sales, 15% Asia sales and 29% US sales, coupled with improved operating leverage. We also raise the P/E multiple to 21x (from 19x earlier) to factor in the industry outperformance in the branded generics segment. We arrive at TP of INR1,435 (from INR1,124 earlier) on 12M forward earnings basis and reiterate Buy.
AJANTPHARM Share Price Target - Broker Reports - 2019
ICICIdirect.com
Price @ Call: 930.36
1-Aug-19
Target: 1010
HOLD
Q1 was largely driven by strong growth in Africa and the US business. While the tender business is expected to remain subdued, the branded business (74% of overall revenues) is likely to grow at 10-11%. US business is expected to grow ~30%, albeit on a lower base. Overall, we expect double digit growth in revenues but dent in gross profit, EBITDA and net profit margins due to a change in the product mix (higher US contribution), new plant related expenses and higher depreciation. We arrive at our target price of Rs 1010 based on 20x FY21E EPS of ~| 50.5.
Reliance Securities
Price @ Call: 990.03
2-Feb-19
Target: 1225
BUY
ICICIdirect.com
Price @ Call: 990.03
1-Feb-19
Target: 1100
BUY
Motilal Oswal
Price @ Call: 1033.62
31-Jan-19
Target: 1390
BUY
AJANTPHARM Share Price Target - Broker Reports - 2018
Motilal Oswal
Price @ Call: 1135.7
1-Aug-18
Target: 1560
BUY
SPA Securities
Price @ Call: 1151.41
9-May-18
Target: 1400
BUY
Arihant Capital Markets
Price @ Call: 1165.4
7-May-18
Target: 1071
REDUCE
Arihant Capital Markets
Price @ Call: 1216.45
4-May-18
Target: 1302
HOLD
Motilal Oswal
Price @ Call: 1341.45
3-May-18
Target: 1560
BUY
Arihant Capital Markets
Price @ Call: 1400.63
3-Apr-18
Target: 1500
BUY
Reliance Securities
Price @ Call: 1370
14-Mar-18
Target: 1860
BUY
SPA Securities
Price @ Call: 1406.1
1-Feb-18
Target: 1520
HOLD
Motilal Oswal
Price @ Call: 1357.91
22-Feb-18
Target: 1840
BUY
Motilal Oswal
Price @ Call: 1532.38
25-Jan-18
Target: 1840
BUY
AJANTPHARM Share Price Target - Broker Reports - 2017
Motilal Oswal
Price @ Call: 1465
20-Dec-17
Target: 1792
BUY
SPA Securities
Price @ Call: 1204.98
13-Nov-17
Target: 1520
BUY
Reliance Securities
Price @ Call: 1232.15
7-Nov-17
Target: 1500
BUY
ICICIdirect.com
Price @ Call: 1214.6
11-Aug-17
Target: 1420
BUY
Motilal Oswal
Price @ Call: 1658
3-May-17
Target: 2028
BUY
ICICIdirect.com
Price @ Call: 1659
4-May-17
Target: 1880
BUY
Motilal Oswal
Price @ Call: 1741
11-Apr-17
Target: 2028
BUY
Motilal Oswal
Price @ Call: 1760
20-Mar-17
Target: 2028
BUY
ICICIdirect.com
Price @ Call: 1701
25-Jan-17
Target: 1960
BUY
AJANTPHARM Share Price Target - Broker Reports - 2016
ICICIdirect.com
Price @ Call: 1543
2-May-16
Target: 1780
BUY
ICICIdirect.com
Price @ Call: 1968
27-Oct-16
Target: 2220
BUY
AnandRathi
Price @ Call: 1932.45
2-Sep-16
Target: 2344
BUY
AnandRathi
Price @ Call: 1605.15
19-Jul-16
Target: 1784
BUY
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
- keyboard_arrow_down
AJANTPHARM Peer Stocks - Share Price Targets
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.